Alembic Pharmaceuticals informs about press release

06 Mar 2026 Evaluate

Alembic Pharmaceuticals has informed that Alembic Therapeutics LLC, a step-down wholly owned subsidiary of the company, has reported its first prescription-based sale in the United States of America (US) following the commercial launch of Pivya® (pivmecillinam) tablets, an oral prescription antibiotic. The company has enclosed its press release in this regard.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

710.45 3.30 (0.47%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×